Effect of an Allergen Vaccine in Patients With Allergic Rhino-Conjunctivitis and Asthma Due to House Dust Mite Allergy

Clinical trial NCT00652223 · COMPLETED

Trial details

NCT number: NCT00652223
Sponsor: Cytos Biotechnology AG
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Perennial Allergic Rhinoconjunctivitis Allergic Asthma

Start date: 2005-03-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.